Navigation Links
Aptel Research Launches Unique Patient-centric Syndicated Report Series That Analyze the Patient Journey for Chronic Diseases in Specialty Markets
Date:9/16/2013

CAMBRIDGE, Mass., Sept. 16, 2013 /PRNewswire/ -- Aptel Research, a specialty marketing research and consulting company that provides actionable strategic insights to the pharmaceutical and biotech industries, today launched Patient Voices Syndicated Report Series™. Patient Voices Syndicated Report Series provides rich insights into the emotional and rational factors that impact the patient journey through specific chronic diseases in specialty markets. The first report covers multiple sclerosis in the United States. Future reports will cover other chronic diseases in the U.S. and in international markets. Each report captures the various aspects of the patient journey from symptoms to diagnosis to treatment, and identifies issues and gaps along the way. The reports employ a mix of qualitative interviews, quantitative surveys, and an analysis of patient social media to create a nuanced understanding of patients' experiences, as well as brand attitudes and unmet needs.

"Patients with relapsing forms of MS are fortunate to have many treatment options now, including oral treatments," said Aptel Research CEO Michele Derai. "The MS landscape is rapidly changing and additional multiple sclerosis agents are in various stages of development in the U.S. and abroad. The Patient Voices Syndicated Report Series will serve the product life-cycle needs of our clients by allowing them to differentiate their products to best match patients' lives and mindsets at any point in their journey. The insights provided by the Patient Voices Syndicated Report Series will enable our clients to uncover new marketing opportunities."

With decades of experience, in-depth business and scientific expertise and a global network, Aptel Research offers customized strategic market research from market assessment to branding strategy with key target audiences, including key opinion leaders.

For more information visit Aptel Research.

Media contact:  Jane A. Kramer 781-799-9524


'/>"/>
SOURCE Aptel Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Packaging
2. GSK research estimates significantly higher rates of pertussis among older adults than now reported
3. CVS Caremark Research Finds New, More Accurate Method for Classifying Patient Medication Adherence Behaviors
4. BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project
5. Seahorse XF Technology Helps P&G Research the Science of Skin
6. Pharmaceutical Giants Back Researchers in Unique US Competition
7. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
8. MPI Research Breaks Ground On New World-Class Imaging Center
9. New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
10. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
11. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
Breaking Medicine News(10 mins):